Antithrombin Katowice: exon 1 deletion in the SERPINC1 gene associated with type I antithrombin deficiency

Blood Coagul Fibrinolysis. 2015 Jan;26(1):95-7. doi: 10.1097/MBC.0000000000000182.

Abstract

Type I antithrombin deficiency is an autosomal dominant disorder associated with thromboembolic complications mainly related to single-point mutations in SERPINC1, the gene encoding antithrombin. Chromosomal rearrangements have been found in up to 10% of cases with type I antithrombin deficiency. We report here the first heterozygous deletion of SERPINC1 exon 1 identified in a 44-year-old man with type I deficiency who developed deep vein thrombosis of the left leg complicated by pulmonary embolism. This study demonstrates that the search for large gene rearrangements in SERPINC1 can be a useful diagnostic approach, particularly in patients with type I antithrombin deficiency without mutations in SERPINC1.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antithrombin III / genetics*
  • Exons
  • Fibrin / deficiency*
  • Gene Deletion
  • Humans
  • Male
  • Mutation
  • Pulmonary Embolism / genetics

Substances

  • SERPINC1 protein, human
  • Antithrombin III
  • Fibrin